NeRRe Therapeutics Funding: $43M Raised, Series B (2021)
NeRRe Therapeutics is based in Stevenage, UK. It has raised $43M in total funding. Latest round: Series B.
NeRRe Therapeutics funding overview
NeRRe Therapeutics is based in Stevenage, UK. NeRRe Therapeutics has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for NeRRe Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Columbus Venture Partners, Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed, UK Government’s Future Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
NeRRe Therapeutics at a glance
Total raised
$43M
Latest round
Series B
Latest round date
July 2021
Headquarters
Stevenage, UK
Notable investors
Columbus Venture Partners, Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed, UK Government’s Future Fund, Novo A/S
Frequently asked about NeRRe Therapeutics funding
How much has NeRRe Therapeutics raised?
NeRRe Therapeutics has raised $43M in total disclosed funding across the rounds on record.
Who has invested in NeRRe Therapeutics?
Columbus Venture Partners, Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners, OrbiMed, UK Government’s Future Fund are named among the investors backing NeRRe Therapeutics.
What was the latest NeRRe Therapeutics funding round?
The most recent disclosed round is a Series B, announced in July 2021.
Where is NeRRe Therapeutics based?
NeRRe Therapeutics is based in Stevenage, UK.
When did NeRRe Therapeutics last raise?
The last disclosed NeRRe Therapeutics round closed in July 2021 at Series B.
We update the NeRRe Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Stevenage and their backers are listed below.
